The Expanding Continuum of Care in NRG1 Fusion-Positive Cancers
Expert Insights on NRG1 Fusions as Driver Alterations and Therapeutic Targets
October 28th 2021
Investigations of Targeted Therapies for NRG1 Fusion–Positive Cancers
October 28th 2021
Advancements in Targeting NRG1 Fusions in Solid Tumors
October 27th 2021
